TABLE 1.
VRSA strains and associated VRE isolates in this study
| Strain | Strain no. | Site | Mo/yr of isolation | MIC (μg/ml)a
|
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CC | DAP | DOX | ERY | GM | OXA | LEV | LNZ | PEN | Q/D | RIF | STR | TEC | VAN | ||||
| VRSA-4 | HIP14300 | Foot wound | 02/2005 | >16 | ≤0.5 | ≤0.25 | >8 | ≤2 | >16 | >16 | 2 | ≥2 | 0.5 | ≤0.5 | ND | 16 | 256 |
| E. faecalis | HIP14333 | Rectum | 02/2005 | ND | ND | 8 | >8 | >500 | ND | >8 | 2 | 4 | 16 | 1 | ≤1,000 | 128 | 1,024 |
| VRSA-5 | HIP15178 | Surgical wound | 10/2005 | >16 | ≤0.5 | ≤0.5 | >8 | ≤2 | >16 | >16 | 4 | >2 | 2 | ≤0.5 | ND | 8 | 512 |
| E. faecalis | HIP15179 | Co-isolated with VRSA | 10/2005 | ND | 1 | ≤2 | >8 | >500 | ND | 8 | 4 | 2 | 8 | 2 | >1,000 | 64 | 512 |
| VRSA-6 | AIS2006032 | Foot wound | 12/2005 | >16 | 1 | 1 | >8 | ≤2 | >16 | >16 | 2 | >2 | 1 | ≤0.5 | ND | 16 | 1,024 |
| E. faecalis | AIS2007003 | Rectum | 12/2005 | ND | 2 | 4 | >8 | >500 | ND | >8 | 2 | 2 | 16 | 1 | >1,000 | 64 | >512 |
| E. avium | AIS2007004 | Rectum | 12/2005 | ND | 1 | 8 | >8 | >500 | ND | 8 | 2 | 2 | ND | 1 | ≤1,000 | 8 | 256 |
| VRSA-7 | AIS2006049 | Arm wound | 10/2006 | >16 | 2 | ≤1 | >8 | ≤2 | >16 | 8 | 2 | >2 | 0.5 | ≤0.5 | ND | 16 | 512 |
a
Abbreviations: CC, clindamycin; DAP, daptomycin; DOX, doxycycline; ERY, erythromycin; GM, gentamicin; OXA, oxacillin, LEV, levofloxacin; LNZ, linezolid, PEN, penicillin; Q/D, quinupristin-dalfopristin; STR, streptomycin; TEC, teicoplanin, TET, tetracycline, VAN, vancomycin; ND, not determined.